Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin. Here's the filing, end of transmission. As we have nothing else to add. AKA...
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery...

COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement

Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million tied to exercise of...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests NeuroDirect™ Ketamine....

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note from Cantheon Capital for in-human trials...

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...

A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of applying NeuroDirect™ ketamine topical...

Video: New Topical Drug Delivery System, NeuroDirect™

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can this be used for Ketamine treatments? Time will tell, as they are...

Topical PTSD Drug Poised for Human Trials.

In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic...
Zappy Zapolin, Lamar Odom, Roland Rick Perry

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.

Above: Lamar Odom and Psychedelic Spokesman Mike Zappy Zapolin We're Calling a Sector Bottom, and Psycheceutical (BWVI) as Our Favorite. We launched the Psychedelic Stock Review...

The Ketamine Endgame. Silo Pharmaceutical (SILO).

James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference. Dr....

Latest article

Road Trip to Nevada, to Meet World Renowned Geologist, Dr. Sergei Diakov.

Adding Fairchild Gold (FAIR) $0.035 to the Watch List. The Thrilla and Manilla, and the Nirvana in Nevada. What does Manilla have to do with Nevada?...

Maxim Group, Critical Minerals Summit

The group of 'Critical Minerals' companies in our Universe are on a tear. Learn more via this timely presentation put together by Maxim Group....

Adding Emergent Biosolutions (EBS) $6.95 to Watch List.

We originally heard about Emergent last February when it was hitting a new low, near $1.50. Within weeks it ran to $3.50 and we...